Scopus
🔓 Açık Erişim YÖKSİS DOI Eşleşti
SJR Q2
Health technology assessment in Türkiye: Current status and perspectives on future implementation
Health Policy and Technology · Mart 2023
YÖKSİS Kayıtları
Health technology assessment in Türkiye: Current status and perspectives on future implementation
Health Policy and Technology · 2023 SSCI
Dr. Öğr. Üyesi HARUN KIZILAY →
YÖKSİS Kayıtları — ISSN Eşleşmesi
Budget impact of incorporating non-invasive prenatal testing in prenatal screening for Down syndrome in Turkey
2019 ISSN: 22118837 SSCI
Prof. Dr. GÖKÇEN ÖRGÜL →
Health technology assessment in Türkiye: Current status and perspectives on future implementation
2023 ISSN: 2211-8837 SSCI Q1
Dr. Öğr. Üyesi HARUN KIZILAY →
Makale Bilgileri
ISSN22118837
Yayın TarihiMart 2023
Cilt / Sayfa12
Scopus ID2-s2.0-85143850051
Erişim🔓 Açık Erişim
Özet
Objective:: Türkiye's health care system reforms have led not only to increased access to health care but also to rising pharmaceutical expenditures. Therefore, health technology assessment (HTA) has become an important tool for evaluating priorities in reimbursement and budget allocation. Our study aimed to describe the current HTA environment in Türkiye and explore long-term perspectives from a broad spectrum of Turkish stakeholders on the development of HTA in the next ten years. Methods:: In 2019, we used a convenience sampling method to conduct an online survey with stakeholders from different areas in the health system. Additional face-to-face discussions were conducted to clarify answers when needed. We assessed the current evaluation process for pharmaceuticals and examined the need for HTA in Türkiye. Online survey data were extracted into Microsoft Excel for analysis. Quantitative data were summarised descriptively. Results:: A total of 27 Turkish stakeholders completed the survey; 21 were employed in the public sector, and 6, in the private sector. The majority of participants (18/27) suggested introducing HTA for all new health technologies considered for public reimbursement and instituting an additional review process for currently reimbursed technologies. Most respondents (25/27) agreed that a threshold for cost-effectiveness should be applied in the next ten years. Conclusion:: The stakeholders concurred that Türkiye must implement an HTA process soon. However, further discussion and interaction between stakeholders are essential to ensure a broad commitment to the implementation of a structured HTA process in Türkiye.
Yazarlar (8)
1
E. Kağan Atikeler
ORCID: 0000-0002-8655-4877
2
Ahmad Nader Fasseeh
ORCID: 0000-0001-9878-7734
3
Aukje K. Mantel-Teeuwisse
ORCID: 0000-0002-8782-0698
4
Zafer Çalışkan
ORCID: 0000-0001-9221-6578
5
Z. Gülşen Öner
6
Harun Kızılay
ORCID: 0000-0003-3660-0721
7
Zoltan Kalo
ORCID: 0000-0001-7762-2607
8
Wim Goettsch
Anahtar Kelimeler
Economic evaluation
Evidence-based health policy
Health technology assessment (HTA)
HTA implementation
Turkish healthcare decision-making
Türkiye(Turkey)
Kurumlar
Eötvös Loránd Tudományegyetem
Budapest Hungary
Hacettepe Üniversitesi
Ankara Turkey
National Health Care Institute
Diemen Netherlands
Selçuk Üniversitesi
Selçuklu Turkey
Semmelweis Egyetem
Budapest Hungary
Social Security Institution
Ankara Turkey
Syreon Middle East
Cairo Egypt
Syreon Research Institute
Budapest Hungary
Utrechts Instituut voor Farmaceutische Wetenschappen
Utrecht Netherlands
Scimago Dergi (ISSN Eşleşmesi)
Health Policy and Technology
Q2
SJR Skoru0,720
H-Index43
YayıncıElsevier B.V.
ÜlkeNetherlands
Biomedical Engineering (Q2)
Health Policy (Q2)
Metrikler
3
Atıf
8
Yazar
6
Anahtar Kelime